CME Group Inc.
274.70USD
-3.5300 (-1.27%)
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 5.0B | 5.6B | 6.1B | 6.5B | 7.0B | 7.4B |
| Q1 | 1.3B | 1.4B | 1.5B | 1.6B | 1.9B | — |
| Q2 | 1.2B | 1.4B | 1.5B | 1.7B | 1.7B | — |
| Q3 | 1.2B | 1.3B | 1.6B | 1.5B | 1.7B | — |
| Q4 | 1.2B* | 1.4B* | 1.5B* | 1.6B* | 1.7B | — |
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 7.40 | 8.86 | 9.67 | 11.16 | 12.25 | 12.91 |
| Q1 | 1.95 | 2.43 | 2.35 | 2.62 | 3.18 | — |
| Q2 | 1.82 | 2.14 | 2.42 | 2.81 | 2.88 | — |
| Q3 | 1.87 | 2.06 | 2.50 | 2.49 | 2.94 | — |
| Q4 | 1.78* |
Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.
| 2.27* |
| 2.43* |
| 3.28* |
| 2.96 |
| — |